Sanofi (SNY) Gross Profit (2016 - 2026)
Sanofi's Gross Profit history spans 16 years, with the latest figure at $9.5 billion for Q1 2026.
- On a quarterly basis, Gross Profit rose 16.91% to $9.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $39.6 billion, a 24.49% increase, with the full-year FY2025 number at $39.2 billion, up 18.0% from a year prior.
- Gross Profit hit $9.5 billion in Q1 2026 for Sanofi, up from -$8.2 billion in the prior quarter.
- Over the last five years, Gross Profit for SNY hit a ceiling of $34.7 billion in Q4 2023 and a floor of -$8.2 billion in Q4 2025.
- Historically, Gross Profit has averaged $10.2 billion across 5 years, with a median of $8.1 billion in 2025.
- Biggest five-year swings in Gross Profit: skyrocketed 339.86% in 2023 and later tumbled 242.49% in 2025.
- Tracing SNY's Gross Profit over 5 years: stood at $7.9 billion in 2022, then skyrocketed by 339.86% to $34.7 billion in 2023, then tumbled by 83.47% to $5.7 billion in 2024, then tumbled by 242.49% to -$8.2 billion in 2025, then soared by 216.28% to $9.5 billion in 2026.
- Business Quant data shows Gross Profit for SNY at $9.5 billion in Q1 2026, -$8.2 billion in Q4 2025, and $29.5 billion in Q3 2025.